Madrigal Pharmaceuticals Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Bill Sibold
Chief Executive Officer (CEO)
US$32.9m
Compensación total
Porcentaje del salario del CEO | 0.8% |
Permanencia del CEO | less than a year |
Participación del CEO | n/a |
Permanencia media de la dirección | less than a year |
Promedio de permanencia en la Junta Directiva | 7.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage
Apr 24Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge
Mar 15Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potential
Feb 07Calculating The Intrinsic Value Of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Dec 20We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Aug 05Madrigal: Buy And Hoard Before Q4 Data Readout
Aug 04Madrigal cut to Neutral at B. Riley on concerns over upcoming NASH readout
Jul 08Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Could Be 45% Below Their Intrinsic Value Estimate
May 11Madrigal: NASH Data In Q4 Is The Key
Apr 19We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Feb 24Madrigal: Delayed NASH Data Is Positive But Real Tests Are Still To Come
Jan 31Madrigal: Powerful Catalyst Approaching
Jan 09We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Nov 08We're Keeping An Eye On Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Rate
Jul 26Madrigal Pharmaceuticals: Leading The NASH Innovation
May 05Here's Why We're Watching Madrigal Pharmaceuticals' (NASDAQ:MDGL) Cash Burn Situation
Apr 12We Think Madrigal Pharmaceuticals (NASDAQ:MDGL) Can Afford To Drive Business Growth
Dec 28Madrigal Pharma: A Look At The Early MAESTRO Trial Data
Nov 27Madrigal Pharmaceuticals (MDGL) Presents At AASLD 2020 Conference- Slideshow
Nov 17Madrigal Pharmaceuticals EPS misses by $0.40
Nov 05Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$444m |
Dec 31 2023 | US$33m | US$275k | -US$374m |
Compensación vs. Mercado: La compensación total de Bill($USD32.87M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD8.44M).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Bill con los resultados de la empresa.
CEO
Bill Sibold (57 yo)
less than a year
Permanencia
US$32,871,801
Compensación
Mr. William J. Sibold, also known as Bill, serves as Chief Executive Officer, President and Director at Madrigal Pharmaceuticals, Inc. since September 8, 2023. Mr. Sibold joined Madrigal Pharmaceuticals, I...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | less than a year | US$32.87m | sin datos | |
Founder | 12.7yrs | US$6.93m | 5.11% $ 250.2m | |
Executive Officer | less than a year | US$5.27m | 0.016% $ 764.7k | |
Executive Officer | less than a year | US$5.26m | 0.013% $ 616.0k | |
Chief Commercial Officer | less than a year | US$3.14m | sin datos | |
CFO & Senior VP | less than a year | sin datos | sin datos | |
Chief Information Officer | less than a year | sin datos | sin datos | |
Chief Investor Relations Officer | less than a year | sin datos | sin datos | |
VP, Senior Associate General Counsel & Assistant Secretary | no data | sin datos | sin datos | |
Chief Human Resources Officer | less than a year | sin datos | sin datos | |
Senior Vice President of Clinical & Technical Operations | no data | sin datos | sin datos | |
Senior Vice President of Clinical Management | no data | sin datos | sin datos |
0.3yrs
Permanencia media
58.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MDGL no se considera experimentado ( 0.5 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | less than a year | US$32.87m | sin datos | |
Founder | 7.8yrs | US$6.93m | 5.11% $ 250.2m | |
Independent Lead Director | 7.8yrs | US$65.00k | 2.2% $ 107.7m | |
Independent Director | 7.8yrs | US$77.50k | 0% $ 0 | |
Independent Chairman of the Board | less than a year | US$33.75k | 0% $ 0 | |
Director | 7.8yrs | US$9.80m | 4.3% $ 210.3m | |
Independent Director | 7.8yrs | US$62.50k | 0.043% $ 2.1m | |
Independent Director | 4.9yrs | US$57.50k | 0% $ 0 | |
Independent Director | less than a year | US$27.50k | 0% $ 0 |
7.8yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: La junta directiva de MDGL se considera experimentada (7.7 años de antigüedad promedio).